What does this research mean for the field?

The ELISA potency assay is suitable for determining the potency of inactivated H5 A/Astrakhan/3212/2020 influenza vaccines. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to evaluate an ELISA-based assay for measuring the potency of H5 clade 2.3.4.4b influenza vaccines.

February 27, 2026

A Monoclonal Antibody ELISA-Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines.

Key Points

This study aims to evaluate an ELISA-based assay for measuring the potency of H5 clade 2.3.4.4b influenza vaccines.
Developed an ELISA potency assay
Tested inactivated H5 A/Astrakhan/3212/2020 vaccines
Prepared libraries of antibody reagents for influenza subtypes
The ELISA potency assay is suitable for vaccine potency determination
The study emphasizes the need for mAb libraries for influenza vaccines
Findings support the development of alternative mAb potency assays

Abstract

The results demonstrated that the ELISA potency assay is suitable for determining the potency of inactivated H5 A/Astrakhan/3212/2020 influenza vaccines. Moreover, the results demonstrate the importance of preparing libraries of antibody reagents for influenza subtypes with pandemic potential so that suitable mAbs are available for development of alternative mAb vaccine potency assays when needed.

A Monoclonal Antibody ELISA-Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines.

Key Points

Abstract

Cite This Study